| P50 | author | Minetaro Arita | Q56428193 |
| P2093 | author name string | Angel S Galabov | |
| | Stefan Philipov | |
| P2860 | cites work | Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo | Q36970004 |
| | A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ. | Q37263877 |
| | The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication | Q38033958 |
| | Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. | Q39023918 |
| | Fisetin and rutin as 3C protease inhibitors of enterovirus A71. | Q39371556 |
| | Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin | Q39474460 |
| | A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection. | Q39675700 |
| | Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. | Q40222004 |
| | A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. | Q40247187 |
| | The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein | Q40579249 |
| | Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus | Q40882626 |
| | Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. | Q41590405 |
| | Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication | Q42244612 |
| | Avoiding drug-resistance development by novel approach of combining anti-enteroviral substances against coxsackievirus B1 infection in mice | Q43455484 |
| | Antiviral activity of natural occurring flavonoids in vitro | Q44854260 |
| | Treatment with oxoglaucine can enhance host resistance to Candida albicans infection of mice with adjuvant arthritis | Q45076999 |
| | Toll-like receptor-mediated anti-inflammatory action of glaucine and oxoglaucine. | Q45990045 |
| | Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime. | Q46013962 |
| | 4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity | Q50189844 |
| | An RNA virus hijacks an incognito function of a DNA repair enzyme | Q24297078 |
| | ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites | Q24298628 |
| | Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection | Q24306634 |
| | A nucleo-cytoplasmic SR protein functions in viral IRES-mediated translation initiation | Q24337761 |
| | A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling | Q24599676 |
| | Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. | Q27469873 |
| | Targeting Plasmodium PI(4)K to eliminate malaria | Q27974482 |
| | Viral reorganization of the secretory pathway generates distinct organelles for RNA replication | Q28283814 |
| | Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug | Q28360421 |
| | Generation of unique poliovirus RNA replication organelles | Q28540297 |
| | Anti-enterovirus 71 effects of chrysin and its phosphate ester | Q28540436 |
| | Inhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl Phosphate | Q28541413 |
| | Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity | Q33370037 |
| | Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1. | Q34155593 |
| | Antiplasmodial activity of aporphine alkaloids and sesquiterpene lactones from Liriodendron tulipifera L | Q34441633 |
| | Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. | Q34742005 |
| | Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles | Q34769274 |
| | Experimentally guided models reveal replication principles that shape the mutation distribution of RNA viruses | Q35030377 |
| | Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A | Q35234487 |
| | Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein | Q35252021 |
| | Complex dynamic development of poliovirus membranous replication complexes | Q35666111 |
| | Antipicornavirus flavone Ro 09-0179 | Q35718165 |
| | Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole | Q36265401 |
| | Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors | Q36276866 |
| | Picornavirus modification of a host mRNA decay protein | Q36367527 |
| | A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein | Q36481910 |
| | Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. | Q36760237 |
| P433 | issue | 6 | |
| P921 | main subject | Poliovirus | Q70923324 |
| P304 | page(s) | 338-347 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Microbiology and Immunology | Q15767399 |
| P1476 | title | Phosphatidylinositol 4-kinase III beta is the target of oxoglaucine and pachypodol (Ro 09-0179) for their anti-poliovirus activities, and is located at upstream of the target step of brefeldin A | |
| P478 | volume | 59 | |